|
NIH Grants for Pharmacogenomics Research
FY'05 June 13 — July 17 |
||||
|
City, State, or Country Name
|
Organization Name
|
Principal Investigator
|
Award
|
Title
|
| Alabama Birmingham |
University of Alabama at Birmingham | Hughes, Laura B |
$107,043
|
Pharmacogenetics of Methotrexate in Rheumatoid Arthritis |
| California San Francisco |
University of California, San Francisco | Benowitz, Neal L |
$188,512
|
Clinical Pharmacology, Drug Action, & Pharmacogenetics |
| San Francisco | University of California, San Francisco | Giacomini, Kathleen M |
$2,584,827
|
Pharmacogenetics of Membrane Transporters |
| San Francisco | University of California, San Francisco | Szoka, Francis C |
$232,125
|
Pharmaceutical Sciences and Pharmacogenomics |
| San Francisco | University of California, San Francisco | Hauser, Stephen L |
$2,717,681
|
A Haplotype Map for Multiple Sclerosis |
| La Jolla | University of California, San Diego | Nigam, Sanjay K |
$294,525
|
SNPs in Handling of Small Pox Antivirals & Other Drugs |
| Los Angeles | University of California, Los Angeles | Nelson, Stanley F |
$872,727
|
UCLA NINDS/NIMH Microarray Center |
| San Diego | Veterans Medical Research Foundation, San Diego | Patel, Piyush M |
$363,216
|
Microarray analysis of neuronal ischemic preconditioning |
| Colorado Aurora |
University of Colorado Denver/HSC | Aurora Zahniser, Nancy R |
$112,440
|
Behavioral Pharmacogenetics of Drug & Alcohol Abuse |
| Connecticut New Haven |
Yale University | Mane, Shrikant M |
$1,245,816
|
Yale Microarray Center for Research on the Nervous Syste |
| Florida Tampa |
H. Lee Moffitt Cancer Center and Research Institute | Lancaster, Johnathan M |
$81,500
|
Plasma Microarray Analysis and Ovarian Cancer Biomarkers |
| Illinois Chicago |
University of Chicago | Ratain, Mark J |
$3,000,870
|
Pharmacogenetics of Anticancer Agents Research Group |
| Kentucky Louisville |
University of Louisville | Hein, David W |
$398,047
|
Pharmacogenetics of drug and carcinogen metabolism |
| Maryland Baltimore |
Johns Hopkins University | Hidalgo, Manuel |
$297,040
|
Pharmacogenomics of Erlotinib |
| Massachussetts Cambridge |
Harvard University | Liu, Jun |
$326,000
|
Computational Haplotype Analysis for SNPs |
| Boston | Massachusetts General Hospital | Seed, Brian |
$785,548
|
Shared Microarray Facility |
| Boston | Massachusetts General Hospital | Thadhani, Ravi I |
$137,500
|
Antibody Microarray Predicting Pima Diabetic Nephropathy |
| Minnesota Rochester |
Mayo Clinic College of Medicine, Rochester | Weinshilboum, Richard M |
$2,460,531
|
Pharmacogenetics of Phase II Drug Metabolizing Enzymes |
| Rochester | Mayo Clinic College of Medicine, Rochester | Turner, Stephen T |
$859,934
|
Anthipertensive PharmacoGenomics |
| Minneapolis | University of Minnesota, Twin Cities | Tracy, Timothy S |
$241,600
|
Pharmacogenetics and Drug Interactions |
| Missouri St. Louis |
Washington University | Mcleod, Howard L |
$157,638
|
Ovarian Cancer Pharmacogenetics |
| North Carolina Durham |
Duke University | Allen, Andrew S |
$142,101
|
Advanced Haplotype Analyses in Coronary Artery Disease |
| Durham | Duke University | Nevins, Joseph R |
$728,625
|
Functional Microarray Facility |
| Pennsylvania Philadelphia |
University of Pennsylvania | Lerman, Caryn E |
$390,071
|
Pharmacogenetic Investigation of Naltrexone |
| Pittsburgh | University of Pittsburgh | Li, Song |
$367,360
|
Pharmacogenetic Therapy of Pulmonary Hypertension |
| Texas San Antonio |
University of Texas Health Science Center San Antonio | Suh, Yousin |
$288,096
|
Association Analysis of SNPs in Longevity Assurance Gen |
| Utah Salt Lake City |
LDS Hospital | Anderson, Jeffrey L |
$575,237
|
Risk Burden of Lipoprotein Metabolic Gene Haplotypes |
| Washington Seattle |
Fred Hutchinson Cancer Research Center | Zhao, Lue Ping |
$389,250
|
Methods for Correlating SNP Haplotypes with Cancer |
|
*SOURCE: US National Institutes of Health
|
||||
NIH Grants for Pharmacogenomics Research: Jul 21, 2005
Premium